Snapshot · McKesson Corporation (MCK)

Data as of 2026-09-01T11:00:57.956Z

Fundamentals check

Market cap

$103.7B

P/E (TTM)

23.6

Gross margin

3.6%

Net margin

1.1%

ROE

-194.4%

R&D / revenue

0.0%

Dividend yield

0.4%

FCF yield

6.0%

Latest dividend: $0.94/share (ex-date 2026-09-01, quarterly)

Summary

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

How it makes money

Revenue mix, latest fiscal year

• North American Pharmaceutical Segment83.4%
• Oncology And Multispecialty Segment12%
• Medical-Surgical Solutions Segment2.9%
• Prescription Technology Solutions Segment1.4%
• Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment0.3%

Recent Events

• 2026-08-31T14:10:09.000Znegative

  Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson

  可能与网络安全事件相关的后续影响有关，尚不能证实因果

  Source: techcrunch.com

• 2026-08-25T11:31:16.000Zpositive

  McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization

  可能与并购交易及扩展服务相关，尚无确定因果

  Source: benzinga.com

• 2026-08-25T08:17:42.000Zpositive

  McKesson to buy Precision Medicine Group in about $2.25 billion deal

  可能与并购交易及扩展服务相关，尚无确定因果

  Source: reuters.com

• 2026-08-25T00:00:00.000Zpositive

  Price move: MCK rose 3.6%

  MCK 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-08-05T00:00:00.000Zpositive

  MCK filed 10-Q

  可能与此次10-Q披露的盈利或指引更新相关，尚无因果结论

  Source: SEC EDGAR

• 2026-08-05T00:00:00.000Zpositive

  Price move: MCK rose 5.6%

  MCK 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-16T00:00:00.000Zpositive

  Price move: MCK rose 5.6%

  MCK 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-09T00:00:00.000Znegative

  Price move: MCK fell 3.2%

  MCK 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-18T00:00:00.000Znegative

  Price move: MCK fell 3.7%

  MCK 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $948.25 from 4 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-08-10SellLerman Bradley E(director)301 shares
• 2026-07-07SellTYLER BRIAN S.(director, officer: Chief Executive Officer)8,463 shares
• 2026-06-17SellTYLER BRIAN S.(director, officer: Chief Executive Officer)8,463 shares
• 2026-06-09SellTYLER BRIAN S.(director, officer: Chief Executive Officer)4,929 shares
• 2026-06-05SellRutledge Napoleon B JR(officer: SVP, Controller & CAO)133 shares

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。